clinical trials

Big pharma heads towards important readouts
Big pharma heads towards important readouts
EP Vantage
Ozempic
Novo Nordisk
etrolizumab
Roche
Ipatasertib
finerenone
Bayer
filgotinib
Gilead Sciences
Galapagos
Avalglucosidase alfa
Sanofi
Rinvoq
AbbVie
clinical trials
Flag link:
More questions than answers as Moderna's coronavirus vaccine speeds ahead
More questions than answers as Moderna's coronavirus vaccine speeds ahead
BioPharma Dive
Moderna Therapeutics
vaccines
COVID-19
MRNA
clinical trials
mRNA-1273
Flag link:
Johnson & Johnson's Oncology Team Posts Promising Cancer Trial Results
Johnson & Johnson's Oncology Team Posts Promising Cancer Trial Results
Motley Fool
JNJ
Multiple Myeloma
bispecific antibodies
JNJ-5957
teclistamab
clinical trials
Flag link:
COVID-19 could cause surge in virtual trials, says Vertex expert
COVID-19 could cause surge in virtual trials, says Vertex expert
Pharmaforum
COVID-19
pandemic
clinical trials
virtual clinical trials
Vertex Pharmaceuticals
Flag link:
3 Roche Companies Hope to Make Clinical Trials More Efficient
3 Roche Companies Hope to Make Clinical Trials More Efficient
Medical Devices and Diagnostics Industry
Flatiron Health
Foundation Medicine
Genentech
Roche
genomics
clinical trials
lung cancer
Flag link:
Biotech Genfit warns costs of failed NASH trial will drag deep into 2020
Biotech Genfit warns costs of failed NASH trial will drag deep into 2020
Fierce Biotech
Genfit
NASH
clinical trials
elafibranor
Flag link:
Moderna Reveals ‘Positive’ Data In Coronavirus Vaccine Trial, Markets Spike
Moderna Reveals ‘Positive’ Data In Coronavirus Vaccine Trial, Markets Spike
Forbes
Moderna Therapeutics
COVID-19
vaccines
clinical trials
Flag link:
Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
Janssen Presents First Data from Phase 1 Study of BCMAxCD3 Bispecific Teclistamab in Patients with Heavily Pretreated Relapsed or Refractory Multiple Myeloma
BioSpace
JNJ
Janssen
teclistamab
JNJ-7957
clinical trials
ASCO 2020
Multiple Myeloma
Flag link:
NantKwest and ImmunityBio to initiate a phase 2 study of immunotherapy for metastatic pancreatic cancer
NantKwest and ImmunityBio to initiate a phase 2 study of immunotherapy for metastatic pancreatic cancer
Pharmaceutical Business Review
NantKwest
clinical trials
t-aNK
metastatic prostate cancer
Flag link:
Is Inovio Gaining Ground in the Coronavirus Vaccine Race?
Is Inovio Gaining Ground in the Coronavirus Vaccine Race?
Motley Fool
Inovio
Moderna Therapeutics
vaccines
clinical trials
pandemic
COVID-19
Flag link:
BMJ, Nature warn against ‘sabotaging’ COVID-19 response with poor and ‘chaotic’ trials
BMJ, Nature warn against ‘sabotaging’ COVID-19 response with poor and ‘chaotic’ trials
Fierce Biotech
Nature
British Medical
R&D
clinical trials
COVID-19
Flag link:
FDA updates guidance on clinical trials amid COVID-19
FDA updates guidance on clinical trials amid COVID-19
RAPS.org
FDA
clinical trials
pandemic
COVID-19
Flag link:
Pfizer, BioNTech to ramp up COVID-19 vaccine tests, plot major trial boost in fall
Pfizer, BioNTech to ramp up COVID-19 vaccine tests, plot major trial boost in fall
Fierce Biotech
Pfizer
COVID-19
vaccines
BioNTech
clinical trials
Flag link:
Ocular Therapeutix announces first patient dosed in phase 1 clinical trial of OTX-CSI to treat dry eye disease
Ocular Therapeutix announces first patient dosed in phase 1 clinical trial of OTX-CSI to treat dry eye disease
Pharmaceutical Business Review
Ocular Therapeutix
dry eye disease
clinical trials
OTX-CSI
Flag link:
Novartis-backed Gamida hits goal in phase 3 cancer trial
Novartis-backed Gamida hits goal in phase 3 cancer trial
Fierce Biotech
Gamida Cell
Novartis
omidubicel
blood cancer
clinical trials
Flag link:
Genfit Contender in Heated NASH Drug Race Fails in Phase 3 Study
Genfit Contender in Heated NASH Drug Race Fails in Phase 3 Study
Xconomy
Genfit
clinical trials
NASH
elafibranor
Flag link:
MyoKardia’s Heart Drug Shines in Phase 3, FDA Filing Planned for 2021
MyoKardia’s Heart Drug Shines in Phase 3, FDA Filing Planned for 2021
Xconomy
MyoKardia
clinical trials
mavacamten
obstructive hypertrophic cardiomyopathy
Flag link:
Inside the NIH’s controversial decision to stop its big remdesivir study
Inside the NIH’s controversial decision to stop its big remdesivir study
Stat
Gilead Sciences
remdesivir
NIH
clinical trials
COVID-19
pandemic
Flag link:
Large Study Suggests Malaria Drug Hydroxychloroquine Doesn’t Help COVID-19
Large Study Suggests Malaria Drug Hydroxychloroquine Doesn’t Help COVID-19
BioSpace
clinical trials
hydroxychloroquine
COVID-19
Flag link:
Why Moderna's Next Step For Its Coronavirus Vaccine is Crucial
Why Moderna's Next Step For Its Coronavirus Vaccine is Crucial
Motley Fool
Moderna Therapeutics
vaccines
clinical trials
COVID-19
Flag link:

Pages